Greenwich Wealth Management’s Avantis International Equity ETF AVDE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.42M Buy
75,697
+15,698
+26% +$1.36M 0.26% 56
2025
Q4
$4.94M Buy
59,999
+12,333
+26% +$989K 0.22% 64
2025
Q3
$3.76M Buy
47,666
+20,053
+73% +$1.53M 0.19% 70
2025
Q2
$2.04M Buy
27,613
+522
+2% +$36.5K 0.1% 93
2025
Q1
$1.79M Buy
27,091
+9,350
+53% +$608K 0.14% 83
2024
Q4
$1.09M Buy
17,741
+325
+2% +$20.8K 0.08% 116
2024
Q3
$1.17M Sell
17,416
-538
-3% -$34.6K 0.08% 107
2024
Q2
$1.12M Buy
17,954
+781
+5% +$49.6K 0.08% 106
2024
Q1
$1.09M Buy
17,173
+734
+4% +$44.7K 0.09% 105
2023
Q4
$993K Buy
16,439
+3,659
+29% +$207K 0.1% 104
2023
Q3
$711K Buy
12,780
+2,368
+23% +$136K 0.08% 131
2023
Q2
$598K Buy
10,412
+2,730
+36% +$158K 0.06% 142
2023
Q1
$438K Buy
+7,682
New +$433K 0.05% 160

Other funds holding AVDE

Greenwich Wealth Management's AVDE Position: Q1 2026 in Review

Greenwich Wealth Management increased its Avantis International Equity ETF (AVDE) stake by 26% in Q1 2026, buying an estimated $1.36M and bringing the position to 75,697 shares worth $6.42M. The position accounts for 0.26% of the portfolio, ranked #56.

Greenwich Wealth Management first reported a position in AVDE in Q1 2023 and has held it in 13 quarters since. 671 funds tracked by Wall St. Rank hold AVDE as of Q1 2026.

  • Greenwich Wealth Management held 75,697 shares of Avantis International Equity ETF worth $6.42M as of Q1 2026.
  • Greenwich Wealth Management bought 15,698 Avantis International Equity ETF shares in Q1 2026, an estimated $1.36M.
  • Avantis International Equity ETF made up 0.26% of Greenwich Wealth Management's portfolio in Q1 2026, its #56 holding.
  • Greenwich Wealth Management first reported a position in Avantis International Equity ETF in Q1 2023 and has held it in 13 quarters since.
  • 671 funds tracked by Wall St. Rank held Avantis International Equity ETF as of Q1 2026.

Based on Greenwich Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.